Topics

Woodcock: FDA adapting to new clinical trial models, patient goals

05:06 EDT 12 Jul 2019 | SmartBrief

FDA Center for Drug Evaluation and Research Director Janet Woodcock expects the agency's new-drug approval rate to hold stead -More

Original Article: Woodcock: FDA adapting to new clinical trial models, patient goals

NEXT ARTICLE

More From BioPortfolio on "Woodcock: FDA adapting to new clinical trial models, patient goals"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...